These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26885537)

  • 1. Reasons to Investigate the Soluble Receptor for Advanced Glycation End-Product (sRAGE) Pathway in Aortic Disease.
    Sarkar A; Prasad K; Ziganshin BA; Elefteriades JA
    Aorta (Stamford); 2013 Aug; 1(3):210-7. PubMed ID: 26885537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Plasma sRAGE (Soluble Receptor for Advanced Glycation End Products) Is Associated With Slower Carotid Intima-Media Thickness Progression and Lower Risk for First-Time Coronary Events and Mortality.
    Grauen Larsen H; Marinkovic G; Nilsson PM; Nilsson J; Engström G; Melander O; Orho-Melander M; Schiopu A
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):925-933. PubMed ID: 30917679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases?
    Prasad K
    Mol Cell Biochem; 2019 Jan; 451(1-2):139-144. PubMed ID: 29961210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients.
    Assiri AMA; Kamel HFM; ALrefai AA
    Med Sci (Basel); 2018 May; 6(2):. PubMed ID: 29789493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of soluble receptor for advanced glycation end-product with increasing central aortic stiffness in hypertensive patients.
    Yoon SJ; Park S; Park C; Chang W; Cho DK; Ko YG; Choi D; Kwon HM; Jang Y; Chung N
    Coron Artery Dis; 2012 Mar; 23(2):85-90. PubMed ID: 22198512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality.
    Cheng Y; Zhong J; Xiang Y; Zeng F; Cai D; Zhao L
    Clin Interv Aging; 2014; 9():1981-6. PubMed ID: 25429209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
    Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
    Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
    Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum soluble receptor for advanced glycation end products correlates inversely with measures of adiposity in young adults.
    Davis KE; Prasad C; Vijayagopal P; Juma S; Imrhan V
    Nutr Res; 2014 Jun; 34(6):478-85. PubMed ID: 25026914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble receptor for advanced glycation end products in male infertility.
    Charalampidou S; Simitsopoulou Μ; Skoura L; Tziomalos K; Koulourida V; Goulis DG
    Hippokratia; 2017; 21(1):19-24. PubMed ID: 29904252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between serum-soluble receptor for advanced glycation end products (sRAGE) and disease activity in rheumatoid arthritis patients.
    Jafari Nakhjavani MR; Jafarpour M; Ghorbanihaghjo A; Abedi Azar S; Malek Mahdavi A
    Mod Rheumatol; 2019 Nov; 29(6):943-948. PubMed ID: 30474471
    [No Abstract]   [Full Text] [Related]  

  • 12. Decreased levels of soluble receptor for advanced glycation end-products in aortic valve calcification patients.
    Zheng H; Li Y; Xie N; Huang JL; Xu HF; Luo M
    Genet Mol Res; 2015 Apr; 14(2):3775-83. PubMed ID: 25966147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association between soluble receptor for advanced glycation end products (sRAGE) and coronary and cerebral atherosclerosis].
    Yang SH; Han XJ; Hu HY; Chen W; Yang CZ; Tian JP; Guo CX
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(39):3062-3067. PubMed ID: 31648447
    [No Abstract]   [Full Text] [Related]  

  • 14. Association between intraoperative ventilator settings and plasma levels of soluble receptor for advanced glycation end-products in patients without pre-existing lung injury.
    Jabaudon M; Futier E; Roszyk L; Sapin V; Pereira B; Constantin JM
    Respirology; 2015 Oct; 20(7):1131-8. PubMed ID: 26122046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble receptor for advanced glycation end products mitigates vascular dysfunction in spontaneously hypertensive rats.
    Liu Y; Yu M; Zhang L; Cao Q; Song Y; Liu Y; Gong J
    Mol Cell Biochem; 2016 Aug; 419(1-2):165-76. PubMed ID: 27426491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased plasma levels of soluble low density lipoprotein receptor-related protein-1 (sLRP) and the soluble form of the receptor for advanced glycation end products (sRAGE) in the clinical diagnosis of Alzheimer's disease.
    Liang F; Jia J; Wang S; Qin W; Liu G
    J Clin Neurosci; 2013 Mar; 20(3):357-61. PubMed ID: 23228658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of soluble Receptor for Advanced Glycation End-products (RAGE) are associated with a higher risk of mortality in frail older adults.
    Butcher L; Carnicero JA; Gomez Cabrero D; Dartigues JF; Pérès K; Garcia-Garcia FJ; Rodriguez-Mañas L; Erusalimsky JD;
    Age Ageing; 2019 Sep; 48(5):696-702. PubMed ID: 31211360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between soluble receptor for advanced glycation end products (sRAGE), body composition and fat distribution in healthy women.
    Dozio E; Briganti S; Delnevo A; Vianello E; Ermetici F; Secchi F; Sardanelli F; Morricone L; Malavazos AE; Corsi Romanelli MM
    Eur J Nutr; 2017 Dec; 56(8):2557-2564. PubMed ID: 27522371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum soluble receptor for advanced glycation end products levels and aortic augmentation index in early rheumatoid arthritis--a prospective study.
    Tam LS; Shang Q; Li EK; Wong S; Li RJ; Lee KL; Leung YY; Ying KY; Yim CW; Kun EW; Leung MH; Li M; Li TK; Zhu TY; Chui RK; Tseung L; Yu SL; Kuan WP; Yu CM
    Semin Arthritis Rheum; 2013 Feb; 42(4):333-45. PubMed ID: 22920235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced Glycation End Products:Receptors for Advanced Glycation End Products Axis in Coronary Stent Restenosis: A Prospective Study.
    Pearce C; Islam N; Bryce R; McNair ED
    Int J Angiol; 2018 Dec; 27(4):213-222. PubMed ID: 30410293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.